Skip to main content

Animations

MJFF Publications

5541 - 5550 of 8818 Results
Title
Year
  • Year
  • 2017
  • 2016
  • 2011
  • 2016
  • 2025
  • 2017
  • 2018
  • 2016
  • 2019
  • 2017
  • Summary Details
    OPEN
    Title: Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlx110
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysis
    Journal Name: Carbohydrate Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Arm swing as a potential new prodromal marker of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26720
    Citation Count: 163
  • Summary Details
    OPEN
    Title: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00896-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.13937
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Dual role of USP 30 in controlling basal pexophagy and mitophagy
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745595
    Citation Count: 153
  • Summary Details
    OPEN
    Title: Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.337
    Citation Count: 60
  • Summary Details
    RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.011
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.